Rebinyn

Product manufactured by Novo Nordisk

Application Nr Approved Date Route Status External Links
BLA125611 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rebinyn, Coagulation Factor Ix (Recombinant), Glycopegylated, Is A Recombinant Dna-Derived Coagulation Factor Ix Concentrate Indicated For Use In Adults And Children With Hemophilia B For: • On-Demand Treatment And Control Of Bleeding Episodes • Perioperative Management Of Bleeding Limitations Of Use : Rebinyn Is Not Indicated For Routine Prophylaxis In The Treatment Of Patients With Hemophilia B. Rebinyn Is Not Indicated For Immune Tolerance Induction In Patients With Hemophilia B. Rebinyn, Coagulation Factor Ix (Recombinant), Glycopegylated, Is A Recombinant Dna-Derived Coagulation Factor Ix Concentrate Indicated For Use In Adults And Children With Hemophilia B For: • On-Demand Treatment And Control Of Bleeding Episodes • Perioperative Management Of Bleeding Limitations Of Use : Rebinyn Is Not Indicated For Routine Prophylaxis In The Treatment Of Patients With Hemophilia B. Rebinyn Is Not Indicated For Immune Tolerance Induction In Patients With Hemophilia B ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments